NextCure Inc NXTC:NASDAQ

Last Price$4.50NASDAQ Closing Price as of 4:00PM ET 7/01/22

Today's Change-0.20(4.26%)
Bid (Size)$4.29 (1)
Ask (Size)$4.77 (1)
Day Low / High$4.48 - 4.75
Volume149.5 K
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

NextCure Inc ( NASDAQ )

Price: $4.50
Change: -0.20 (4.26%)
Volume: 149.5 K
4:00PM ET 7/01/2022
 
 

DarioHealth Corp ( NASDAQ )

Price: $5.93
Change: -0.21 (3.42%)
Volume: 263.2 K
4:00PM ET 7/01/2022
 
 

Pieris Pharmaceuticals Inc ( NASDAQ )

Price: $2.00
Change: +0.13 (6.95%)
Volume: 179.9 K
4:00PM ET 7/01/2022
 
 

AquaBounty Technologies Inc ( NASDAQ )

Price: $1.55
Change: -0.16 (9.36%)
Volume: 577.3 K
4:00PM ET 7/01/2022
 
 

ContraFect Corp ( NASDAQ )

Price: $3.10
Change: +0.03 (0.98%)
Volume: 82.3 K
4:00PM ET 7/01/2022
 

Read more news Recent News

--Piper Sandler Lowers NextCure's Price Target to $13 From $21, Maintains Overweight Rating
10:05AM ET 5/23/2022 MT Newswires

Price: 3.80, Change: +0.01, Percent Change: +0.26 ...

-- Earnings Flash (NXTC) NEXTCURE Reports Q1 Loss $-0.74
4:05PM ET 5/05/2022 MT Newswires

...

--Ladenburg Thalmann Initiates NextCure at Buy With $16 Price Target
9:43AM ET 3/01/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Needham Adjusts Price Target on NextCure to $14 from $30, Keeps Buy Rating
12:37PM ET 11/05/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionNextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD. View company web site for more details
Address9000 Virginia Manor Road
Beltsville, Maryland 20705
Phone+1.240.399.4900
Number of Employees44
Recent SEC Filing06/24/20224
President, Chief Executive Officer & DirectorMichael S. Richman
Chief Operating OfficerTimothy Mayer
Chief Financial OfficerSteven P. Cobourn
Chief Scientific OfficerSolomon Langermann

Company Highlights

Price Open$4.67
Previous Close$4.70
52 Week Range$3.25 - 9.18
Market Capitalization$124.9 M
Shares Outstanding27.7 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.66
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-30.63%

Analyst Ratings as of 05/31/2022

Buy
5
Overweight
0
Hold
2
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset